Reentry Incentives and Support for Engagement With Contingency Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community.

In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions.

Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD.

The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Contingency Management for Opioid Use Disorder in Inpatients at Assiut University Hospital

NCT07208266

Opioid Use Disorder (OUD)

NOT_YET_RECRUITING NA

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

NCT05288751

Opioid Use Disorder Stimulant Use Disorder

ACTIVE_NOT_RECRUITING NA

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

NCT07129902

Opioid Use Disorder

NOT_YET_RECRUITING NA

Treatment Navigation for Opioid Use Disorder

NCT03398265

Opioid-use Disorder

COMPLETED NA

Recovery Management Checkups for Opioid Use Disorder Experiment

NCT04365920

Opioid-use Disorder

ACTIVE_NOT_RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RISE-CM Intervention

All participants are enrolled in the intervention arm.

Group Type OTHER

Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention

Intervention Type OTHER

Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.